133 related articles for article (PubMed ID: 8387555)
1. Plasma cyclic guanosine 3'-5' monophosphate concentrations and low vascular resistance in human septic shock.
Schneider F; Lutun P; Couchot A; Bilbault P; Tempé JD
Intensive Care Med; 1993; 19(2):99-104. PubMed ID: 8387555
[TBL] [Abstract][Full Text] [Related]
2. In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure.
Schneider F; Lutun P; Boudjema K; Wolf P; Tempé JD
Hepatology; 1994 Jan; 19(1):38-44. PubMed ID: 7903953
[TBL] [Abstract][Full Text] [Related]
3. alpha-atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock.
Hartemink KJ; Groeneveld AB; de Groot MC; Strack van Schijndel RJ; van Kamp G; Thijs LG
Crit Care Med; 2001 Jan; 29(1):80-7. PubMed ID: 11176165
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations of cyclic 3', 5'-guanosine monophosphate in patients with cirrhosis: relationship with atrial natriuretic peptide and haemodynamics.
Kirstetter P; Moreau R; Vachiery F; Gadano A; Soupison T; Pilette C; Pussard E; Cailmail S; Takahashi H; Lebrec D
J Gastroenterol Hepatol; 1997 Mar; 12(3):233-6. PubMed ID: 9142641
[TBL] [Abstract][Full Text] [Related]
5. Plasma cyclic GMP concentrations and their relationship with changes of blood pressure levels in pre-eclampsia.
Schneider F; Lutun P; Baldauf JJ; Quirin L; Dreyfus M; Ritter J; Tempé JD
Acta Obstet Gynecol Scand; 1996 Jan; 75(1):40-4. PubMed ID: 8560995
[TBL] [Abstract][Full Text] [Related]
6. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
[TBL] [Abstract][Full Text] [Related]
8. Acute volume expansion in normal pregnancy and preeclampsia. Effects on plasma atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) concentrations and feto-maternal circulation.
Grunewald C; Nisell H; Carlström K; Kublickas M; Randmaa I; Nylund L
Acta Obstet Gynecol Scand; 1994 Apr; 73(4):294-9. PubMed ID: 8160534
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide and cyclic 3'5'-guanosine monophosphate as indicators of fluid volume overload in children with chronic renal failure.
Lettgen B; Bald M; Valleé H; Bonzel KE; Rascher W
Pediatr Nephrol; 1992 Jan; 6(1):60-4. PubMed ID: 1311187
[TBL] [Abstract][Full Text] [Related]
10. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure.
Tsutamoto T; Kanamori T; Wada A; Kinoshita M
J Am Coll Cardiol; 1992 Sep; 20(3):541-6. PubMed ID: 1324959
[TBL] [Abstract][Full Text] [Related]
11. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment.
Franz M; Woloszczuk W; Hörl WH
Kidney Int; 2000 Jul; 58(1):374-83. PubMed ID: 10886584
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock.
Ueda S; Nishio K; Akai Y; Fukushima H; Ueyama T; Kawai Y; Masui K; Yoshioka A; Okuchi K
Shock; 2006 Aug; 26(2):134-9. PubMed ID: 16878020
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot.
Hayabuchi Y; Matsuoka S; Kuroda Y
Pediatr Cardiol; 1999; 20(5):343-50. PubMed ID: 10441688
[TBL] [Abstract][Full Text] [Related]
14. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
[TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic peptide and cyclic guanosine monophosphate plasma concentrations in patients with thyrotoxicosis and atrial fibrillation. Effect of short-term methimazole therapy.
Czekalski S; Widecka K; Gozdzik J; Ciechanowski K; Krzyzanowska-Swiniarska B; Gromniak E; Gruszczynska M
J Endocrinol Invest; 1994 May; 17(5):341-6. PubMed ID: 8077618
[TBL] [Abstract][Full Text] [Related]
16. [Plasma levels of atrial natriuretic peptide, cyclic guanosine monophosphate and renin following 7.5% NaCl + 6% hydroxyethyl starch or Ringer's lactate. A comparative study of 6 normal subjects].
Furtwängler W; Balogh D; Pomaroli A; Koller J; Wieser C; Mair P
Anaesthesist; 1990 Oct; 39(10):499-504. PubMed ID: 1703729
[TBL] [Abstract][Full Text] [Related]
17. Concomitant increase in plasma atrial natriuretic peptide and cyclic GMP during volume loading.
Weil J; Lang RE; Suttmann H; Rampf U; Bidlingmaier F; Gerzer R
Klin Wochenschr; 1985 Dec; 63(24):1265-8. PubMed ID: 3003451
[TBL] [Abstract][Full Text] [Related]
18. Relationship between plasma levels of atrial natriuretic peptide and cyclic guanosine monophosphate in patients with heart diseases.
Nakaoka H; Imataka K; Kitahara Y; Fujii J; Ishibashi M; Yamaji T
Jpn Circ J; 1988 Jan; 52(1):30-4. PubMed ID: 2834571
[TBL] [Abstract][Full Text] [Related]
19. [Acute reduction of increased atrial natriuretic peptide level and cyclic guanosine monophosphate in patients with chronic heart failure caused by beta-adrenergic stimulation with dopexamine hydrochloride. Correlation with hemodynamic parameters].
Stangl K; Baumann G; Weil J; Gerzer R; Kerscher M; Blömer H
Z Kardiol; 1990 Jun; 79(6):417-23. PubMed ID: 1974099
[TBL] [Abstract][Full Text] [Related]
20. Plasma atrial natriuretic peptide and cyclic nucleotide levels before and after a marathon.
Lijnen P; Hespel P; M'Buyamba-Kabangu JR; Goris M; Lysens R; Vanden Eynde E; Fagard R; Amery A
J Appl Physiol (1985); 1987 Sep; 63(3):1180-4. PubMed ID: 2820919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
